Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Newsletter 2022

Newsletter February 2022: A step forward in loco-regional anaesthesia safety

Marc Giménez-Milà MD, PhD, EDAIC, EDIC. Consultant in Anaesthesia and Intensive Care. Hospital CLINIC de Barcelona.


We would certainly agree that clinical experiences encountered throughout specialist training are imprinted in our own memory. In my case, one of these moments was the diagnosis of an epidural haematoma in a patient with an epidural catheter for postoperative analgesia. Following accidental epidural catheter removal, the patient developed paraplegia which led to clinical suspicion that was, unfortunately, confirmed by emergent Magnetic Resonance Imaging. Although relatively rare, with an incidence of 1 in 168000 in obstetrics, an epidural haematoma is accompanied by severe neurological disability despite prompt diagnosis and treatment (1). A devastating complication, which is precisely one of the motivations of the recently published guidelines in EJA this February by Kietaibl S et al (2) in a combined effort from ESAIC and ESRA. In the following text, we will try not to reveal all findings while we expose the headlines of selected recommendations on the performance of regional anaesthesia in patients taking antithrombotic drugs. In any case, we would like to have the full article marked as a reference text for all clinical anaesthesiologists, especially those practising loco-regional anaesthesia.

The ambitious plan to go beyond time interval recommendations before and after regional technique or catheter removal in order to reduce the risk of haematoma in patients taking antithrombotic agents (3) is well articulated with the proposed final 40 recommendations. The authors analyse whether the time interval should be modified according to different settings, which include prophylactic and therapeutic dosing of antithrombotic drugs, combinations of drugs, assessment of bleeding risk scores, drug measurements and ultrasound guidance to perform the block.

The panel of experts disclose that recommendations are mostly based on clinical studies with limitations in number and quality with a relatively low grade of evidence. A wide range of studies was included comprising randomised trials, retrospective studies and case reports on surgical and obstetric patients older than 16 with a total of 212 references.

Blocks are classified according to bleeding risk in 2 groups: neuroaxial / deep nerve blocks, and a second one with all superficial nerve blocks that are considered to be compressible and unlikely to be complicated with haematoma. The first group of blocks (i.e. epidural, thoracic paravertebral, psoas compartment, deep cervical plexus) need a specific time interval relative to each antiplatelet and anticoagulant drug. These recommendations are mainly based on pharmacokinetic parameters such as t1/2; for low dose drugs twice t1/2 are recommended while high dose drugs 4 to 5 times t1/2 are encouraged. However, these time intervals can vary according to renal function and for an eventual traumatic puncture. The use of ultrasound to perform the blocks was not considered a reason to modify time intervals.

While we wait for more studies on nerve blocks with less clinical experience (Erector spinae plane, pericapsular nerve group) and direct oral anticoagulants, these guidelines will provide knowledge that can be incorporated in daily clinical practice to reduce haemorrhagic events after neuroaxial or peripheral nerve blocks.



  1. Ruppen W, Derry S, McQuay H, Moore RA: Anesthesiology. 2006, 105: 394-399.
  2. Sibylle Kietaibl, Raquel Ferrandis, Anne Godier, et al. European Journal of Anaesthesiology. DOI:10.1097/EJA.0000000000001600
  3. Nishimura RA, Otto CM, Bonow RO, et al. Circulation 2017; 135:e1159–e1195.

Related news

See all news